News
Blood test might detect multiple cancer types, study suggests
March 31, 2020
The test, which uses methylation patterns in plasma cell-free DNA, had specificity and sensitivity approaching those needed for population-based screening.
News
Top 10 must-dos in ICU in COVID-19 include prone ventilation
March 31, 2020
One expert involved in the development of the first international guidelines on the management of critically ill patients with COVID-19 highlights the essential recommendations and explains the rationale behind prone ventilation.
News
New guidance on management of acute CVD during COVID-19
March 31, 2020
Expert guidance comes from Chinese cardiology and infectious disease specialists on how to manage severe emergent cardiovascular disease during COVID-19.
![1]()
News
FDA issues EUA allowing hydroxychloroquine sulfate, chloroquine phosphate treatment in COVID-19
March 31, 2020
The Strategic National Stockpile will work with FEMA to ship the products to states.
![1]()
Opinion
Are psychiatrists more prepared for COVID-19 than we think?
March 31, 2020
Psychiatrists are on the cutting edge of how to address the pandemic of fear and uncertainty gripping individuals and society across the nation, said Dr. Jacqueline Posada.
![1]()
News
Physician couples draft wills, face tough questions amid COVID-19
March 30, 2020
Spouses working in health care confront childcare dilemmas, quarantine questions, and health considerations as the pandemic continues.
News
Dapagliflozin trial in CKD halted because of high efficacy
March 30, 2020
An independent data monitoring committee recommended stopping the trial.
![1]()
News
Flu activity measures continue COVID-19–related divergence
March 30, 2020
Fewer samples are testing positive, but flu-related visits are increasing.
Video
Critical care and COVID-19: Dr. Matt Aldrich
March 30, 2020
Matt Aldrich, MD, medical director of critical care at UCSF Health in San Francisco, speaks about critical care issues in COVID-19.
News
Larger absolute rivaroxaban benefit in diabetes: COMPASS
March 29, 2020
The new vascular low dose of rivaroxaban has had a slow start, but these results may stimulate use in patients with diabetes and stable disease.
